Integrated Investment Consultants, LLC Merck & Co., Inc. Transaction History

Integrated Investment Consultants, LLC

$4.55 Billion
Q3 2024

A detailed history of Integrated Investment Consultants, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Integrated Investment Consultants, LLC holds 613,412 shares of MRK stock, worth $60.1 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares

613,412

Previous 15,816 3778.43%

Holding current value

$60.1 Million

Previous $1.96 Million 3457.66%

% of portfolio

1.53%

Previous 0.57%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$111.15 - $128.97 $66.4 Million - $77.1 Million	597,596 Added 3778.43%	613,412 $69.7 Million
Q1 2024 Apr 18, 2024	SELL	$113.24 - $131.95 $147,438 - $171,798	-1,302 Reduced 7.61%	15,816 $2.09 Million
Q4 2023 May 28, 2024	BUY	$100.18 - $109.02 $2,003 - $2,180	20 Added 0.13%	15,815 $1.72 Million
Q4 2023 Jan 23, 2024	BUY	$100.18 - $109.02 $28,350 - $30,852	283 Added 1.68%	17,118 $1.87 Million
Q3 2023 May 28, 2024	SELL	$102.95 - $114.33 $2,161 - $2,400	-21 Reduced 0.13%	15,795 $1.63 Million
Q3 2023 Oct 17, 2023	SELL	$102.95 - $114.33 $98,832 - $109,756	-960 Reduced 5.39%	16,835 $1.73 Million
Q2 2023 Jul 18, 2023	SELL	$108.61 - $118.38 $133,155 - $145,133	-1,226 Reduced 6.45%	17,795 $2.05 Million
Q1 2023 Jul 18, 2023	SELL	$102.94 - $114.86 $13,999 - $15,620	-136 Reduced 0.76%	17,659 $1.88 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $31,390 - $40,247	359 Added 1.92%	19,021 $2.11 Million
Q3 2022 Nov 21, 2022	SELL	$84.53 - $94.96 $38,207 - $42,921	-452 Reduced 2.36%	18,662 $1.61 Million
Q2 2022 Jul 19, 2022	BUY	$83.49 - $94.64 $65,790 - $74,576	788 Added 4.3%	19,114 $1.74 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $53,294 - $59,740	-725 Reduced 3.81%	18,326 $1.5 Million
Q4 2021 Jan 10, 2022	SELL	$72.28 - $90.54 $10,914 - $13,671	-151 Reduced 0.79%	19,051 $1.46 Million
Q3 2021 Oct 28, 2021	SELL	$71.68 - $78.83 $17,489 - $19,234	-244 Reduced 1.25%	19,202 $1.44 Million
Q2 2021 Jul 21, 2021	BUY	$70.31 - $77.77 $141,885 - $156,939	2,018 Added 11.58%	19,446 $1.51 Million
Q1 2021 Apr 20, 2021	SELL	$68.86 - $81.11 $140,061 - $164,977	-2,034 Reduced 10.45%	17,428 $1.34 Million
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $76,363 - $84,747	1,064 Added 5.78%	19,462 $1.59 Million
Q2 2020 Aug 04, 2020	BUY	$70.42 - $80.13 $2,535 - $2,884	36 Added 0.2%	18,398 $1.42 Million
Q1 2020 May 22, 2020	SELL	$63.36 - $87.82 $95,736 - $132,696	-1,511 Reduced 7.6%	18,362 $1.41 Million
Q4 2019 Jan 29, 2020	SELL	$77.58 - $87.54 $324,051 - $365,654	-4,177 Reduced 17.37%	19,873 $1.81 Million
Q3 2019 Oct 21, 2019	SELL	$76.08 - $82.93 $114,120 - $124,395	-1,500 Reduced 5.87%	24,050 $2.03 Million
Q2 2019 Jul 16, 2019	SELL	$69.84 - $81.59 $272,376 - $318,201	-3,900 Reduced 13.24%	25,550 $2.14 Million
Q1 2019 Apr 26, 2019	SELL	$69.58 - $79.36 $164,208 - $187,289	-2,360 Reduced 7.42%	29,450 $2.45 Million
Q4 2018 Feb 04, 2019	SELL	$65.24 - $75.71 $4,566 - $5,299	-70 Reduced 0.22%	31,810 $2.43 Million
Q2 2018 Aug 09, 2018	SELL	$50.83 - $59.72 $6.44 Million - $7.57 Million	-126,685 Reduced 79.89%	31,880 $1.94 Million
Q2 2018 Aug 01, 2018	BUY	$50.83 - $59.72 $6.43 Million - $7.56 Million	126,541 Added 395.14%	158,565 $2.06 Million
Q1 2018 Apr 12, 2018	BUY	$50.96 - $59.23 $18,600 - $21,618	365 Added 1.15%	32,024 $1.74 Million
Q3 2017 Oct 26, 2017	BUY	$58.67 - $63.13 $1.86 Million - $2 Million	31,659	31,659 $2.03 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Investment Consultants, LLC with notifications on news.

Account

Integrated Investment Consultants, LLC Merck & Co., Inc. Transaction History